Toward standardized high-throughput serum diagnostics: Multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer

Journal of Biomolecular Screening

Volumn 16, Issue 9, 2011, Pages 1018-1026

  Bünger, Stefanie ^a   Haug, Ulrike ^b   Kelly, Frances Maria ^c   Klempt Giessing, Katja ^a   Cartwright, Andrew ^c   Posorski, Nicole ^d   Dibbelt, Leif ^a   Fitzgerald, Stephen Peter ^c   Bruch, Hans Peter ^a   Roblick, Uwe Johannes ^a   Von Eggeling, Ferdinand ^d   Brenner, Hermann ^b   Habermann, Jens Karsten ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Randox Laboratories Ltd   (United Kingdom)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

colon cancer; cytokines; interleukin 8; multiplex protein array biochip; serum diagnostics

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BIOCHIP; BLOOD LEVEL; BLOOD SAMPLING; CANCER PATIENT; CANCER RESEARCH; CANCER SCREENING; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053528075     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111414894     Document Type: Article

References (50)

1. Parkin D. M., Bray F., Ferlay J., Pisani P. Global Cancer Statistics, 2002. CA Cancer J. Clin. 2005 ; 55 (2). 74-108 (Pubitemid 40372904)
2. Connell W. PRO: Endoscopic Surveillance Minimizes the Risk of Cancer. Am. J. Gastroenterol. 2004 ; 99 (9). 1631-1633
3. Mak T., Lalloo F., Evans D. G., Hill J. Molecular Stool Screening for Colorectal Cancer. Br. J. Surg. 2004 ; 91 (7). 790-800 (Pubitemid 38901345)
4. Brenner H., Hoffmeister M., Arndt V., Stegmaier C., Altenhofen L., Haug U. Protection from Right- and Left-Sided Colorectal Neoplasms after Colonoscopy: Population-Based Study. J. Natl. Cancer Inst. 2010 ; 102 (2). 89-95
5. Haug U., Hundt S., Brenner H. Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison with Qualitative Tests. Am. J. Gastroenterol. 2010 ; 105 (3). 682-690
6. Levin B., Lieberman D. A., McFarland B., Smith R. A., Brooks D., Andrews K. S., Dash C., Giardiello F. M., Glick S., Levin T. R. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin. 2008 ; 58 (3). 130-160 (Pubitemid 351830299)
7. Schulmann K., Reiser M., Schmiegel W. Colonic Cancer and Polyps. Best Pract. Res. Clin. Gastroenterol. 2002 ; 16 (1). 91-114
8. Hanash S. Integrated Global Profiling of Cancer. Nat. Rev. Cancer. 2004 ; 4 (8). 638-644 (Pubitemid 39025058)
9. Albertsen P. C. Is Screening for Prostate Cancer with Prostate Specific Antigen an Appropriate Public Health Measure?. Acta Oncol. 2005 ; 44 (3). 255-264 (Pubitemid 40904129)
10. Forones N. M., Tanaka M. CEA and CA 19-9 as Prognostic Indexes in Colorectal Cancer. Hepatogastroenterology. 1999 ; 46 (26). 905-908 (Pubitemid 29224762)
11. Franchi F., Pastore C., Izzo P., Calio E. Ca 19-9 in the Monitoring of Colorectal Cancer after Surgery. Med. Oncol. 2001 ; 18 (3). 237-238 (Pubitemid 33097352)
12. Crawford N. P., Colliver D. W., Galandiuk S. Tumor Markers and Colorectal Cancer: Utility in Management. J. Surg. Oncol. 2003 ; 84 (4). 239-248 (Pubitemid 37484790)
13. Katsumata N., Eguchi K., Fukuda M., Yamamoto N., Ohe Y., Oshita F., Tamura T., Shinkai T., Saijo N. Serum Levels of Cytokines in Patients with Untreated Primary Lung Cancer. Clin. Cancer Res. 1996 ; 2 (3). 553-559 (Pubitemid 26099175)
14. Dirix L. Y., Vermeulen P. B., Pawinski A., Prove A., Benoy I., De Pooter C., Martin M., Van Oosterom A. T. Elevated Levels of the Angiogenic Cytokines Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Sera of Cancer Patients. Br. J. Cancer. 1997 ; 76 (2). 238-243 (Pubitemid 27279665)
15. Gadducci A., Ferdeghini M., Castellani C., Annicchiarico C., Prontera C., Facchini V., Bianchi R., Genazzani A. R. Serum Macrophage Colony-Stimulating Factor (M-CSF) Levels in Patients with Epithelial Ovarian Cancer. Gynecol. Oncol. 1998 ; 70 (1). 111-114 (Pubitemid 28368886)
16. Nikiteas N. I., Tzanakis N., Gazouli M., Rallis G., Daniilidis K., Theodoropoulos G., Kostakis A., Peros G. Serum IL-6, TNFalpha and CRP Levels in Greek Colorectal Cancer Patients: Prognostic Implications. World J. Gastroenterol. 2005 ; 11 (11). 1639-1643 (Pubitemid 40520804)
17. Malicki S., Winiarski M., Matlok M., Kostarczyk W., Guzdek A., Konturek P. C. IL-6 and IL-8 Responses of Colorectal Cancer In Vivo and In Vitro Cancer Cells Subjected to Simvastatin. J. Physiol. Pharmacol. 2009 ; 60 (4). 141-146
18. Balkwill F., Mantovani A. Inflammation and Cancer: Back to Virchow?. Lancet. 2001 ; 357 (9255). 539-545 (Pubitemid 32173595)
19. Chechlinska M., Kowalewska M., Nowak R. Systemic Inflammation as a Confounding Factor in Cancer Biomarker Discovery and Validation. Nat. Rev. Cancer. 2010 ; 10 (1). 2-3
20. Dranoff G. Cytokines in Cancer Pathogenesis and Cancer Therapy. Nat. Rev. Cancer. 2004 ; 4 (1). 11-22 (Pubitemid 38111131)
21. FitzGerald S. P., McConnell R. I., Huxley A. Simultaneous Analysis of Circulating Human Cytokines Using a High-Sensitivity Cytokine Biochip Array. J. Proteome Res. 2008 ; 7 (1). 450-455 (Pubitemid 351171159)
22. Molloy R. M., McConnell R. I., Lamont J. V., FitzGerald S. P. Automation of Biochip Array Technology for Quality Results. Clin. Chem. Lab. Med. 2005 ; 43 (12). 1303-1313
23. Fabre S., Dupuy A. M., Dossat N., Guisset C., Cohen J. D., Cristol J. P., Daures J. P., Jorgensen C. Protein Biochip Array Technology for Cytokine Profiling Predicts Etanercept Responsiveness in Rheumatoid Arthritis. Clin. Exp. Immunol. 2008 ; 153 (2). 188-195 (Pubitemid 351989164)
24. Steyerberg E. W., Harrell F. E., Borsboom G. J., Eijkemans M. J., Vergouwe Y., Habbema J. D. Internal Validation of Predictive Models: Efficiency of Some Procedures for Logistic Regression Analysis. J. Clin. Epidemiol. 2001 ; 54 (8). 774-781 (Pubitemid 32722180)
25. Baggiolini M., Clark-Lewis I. Interleukin-8, a Chemotactic and Inflammatory Cytokine. FEBS Lett. 1992 ; 307 (1). 97-101
26. Rubie C., Frick V. O., Pfeil S., Wagner M., Kollmar O., Kopp B., Graber S., Rau B. M., Schilling M. K. Correlation of IL-8 with Induction, Progression and Metastatic Potential of Colorectal Cancer. World J. Gastroenterol. 2007 ; 13 (37). 4996-5002 (Pubitemid 47496833)
27. Terada H., Urano T., Konno H. Association of Interleukin-8 and Plasminogen Activator System in the Progression of Colorectal Cancer. Eur. Surg. Res. 2005 ; 37 (3). 166-172 (Pubitemid 41160149)
28. Ueda T., Shimada E., Urakawa T. Serum Levels of Cytokines in Patients with Colorectal Cancer: Possible Involvement of Interleukin-6 and Interleukin-8 in Hematogenous Metastasis. J. Gastroenterol. 1994 ; 29 (4). 423-429 (Pubitemid 24262709)
29. Dvorak H. F. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy. J. Clin. Oncol. 2002 ; 20 (21). 4368-4380 (Pubitemid 35266299)
30. Kabbinavar F., Hurwitz H. I., Fehrenbacher L., Meropol N. J., Novotny W. F., Lieberman G., Griffing S., Bergsland E. Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) with FU/LV Alone in Patients with Metastatic Colorectal Cancer. J. Clin. Oncol. 2003 ; 21 (1). 60-65
31. Compton C. C., Fielding L. P., Burgart L. J., Conley B., Cooper H. S., Hamilton S. R., Hammond M. E., Henson D. E., Hutter R. V., Nagle R. B. Prognostic Factors in Colorectal Cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med. 2000 ; 124 (7). 979-994 (Pubitemid 30602039)
32. Berghella A. M., Contasta I., Pellegrini P., Del Beato T., Adorno D. Peripheral Blood Immunological Parameters for Use as Markers of Pre-invasive to Invasive Colorectal Cancer. Cancer Biother. Radiopharm. 2002 ; 17 (1). 43-50 (Pubitemid 34211014)
33. Galizia G., Orditura M., Romano C., Lieto E., Castellano P., Pelosio L., Imperatore V., Catalano G., Pignatelli C., De Vita F. Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery. Clin. Immunol. 2002 ; 102 (2). 169-178 (Pubitemid 34171516)
34. Chung Y. C., Chang Y. F. Serum Interleukin-6 Levels Reflect the Disease Status of Colorectal Cancer. J. Surg. Oncol. 2003 ; 83 (4). 222-226
35. Belluco C., Nitti D., Frantz M., Toppan P., Basso D., Plebani M., Lise M., Jessup J. M. Interleukin-6 Blood Level Is Associated with Circulating Carcinoembryonic Antigen and Prognosis in Patients with Colorectal Cancer. Ann. Surg. Oncol. 2000 ; 7 (2). 133-138 (Pubitemid 30164682)
36. Kinoshita T., Ito H., Miki C. Serum Interleukin-6 Level Reflects the Tumor Proliferative Activity in Patients with Colorectal Carcinoma. Cancer. 1999 ; 85 (12). 2526-2531 (Pubitemid 29272736)
37. O'Hara R. J., Greenman J., MacDonald A. W., Gaskell K. M., Topping K. P., Duthie G. S., Kerin M. J., Lee P. W., Monson J. R. Advanced Colorectal Cancer Is Associated with Impaired Interleukin 12 and Enhanced Interleukin 10 Production. Clin. Cancer Res. 1998 ; 4 (8). 1943-1948 (Pubitemid 28369179)
38. Berrahmoune H., Herbeth B., Lamont J. V., Masson C., FitzGerald P. S., Visvikis-Siest S. Heritability for Plasma VEGF Concentration in the Stanislas Family Study. Ann. Hum. Genet. 2007 ; 71 (Pt 1). 54-63 (Pubitemid 44857682)
39. Berrahmoune H., Herbeth B., Lamont J. V., Lambert D., Blankenberg S., Tiret L., FitzGerald P. S., Siest G., Visvikis-Siest S. Association of Classical and Related Inflammatory Markers with High-Sensitivity C-Reactive Protein in Healthy Individuals: Results from the Stanislas Cohort. Clin. Chem. Lab. Med. 2007 ; 45 (10). 1339-1346 (Pubitemid 47557071)
40. Berrahmoune H., Herbeth B., Lamont J. V., FitzGerald P. S., Visvikis- Siest S. Association between TNF and IL-1 Bloc Polymorphisms and Plasma MCP-1 Concentration. Atherosclerosis. 2007 ; 192 (2). 348-353 (Pubitemid 46735934)
41. Banfi G., Corsi M. M., Volpi P. Could Platelet Rich Plasma Have Effects on Systemic Circulating Growth Factors and Cytokine Release in Orthopaedic Applications?. Br. J. Sports Med. 2006 ; 40 (10). 816 (Pubitemid 44526042)
42. Chiappelli M., Borroni B., Archetti S., Calabrese E., Corsi M. M., Franceschi M., Padovani A., Licastro F. VEGF Gene and Phenotype Relation with Alzheimer's Disease and Mild Cognitive Impairment. Rejuvenation Res. 2006 ; 9 (4). 485-493 (Pubitemid 46100670)
43. Sachdeva N., Yoon H. S., Oshima K., Garcia D., Goodkin K., Asthana D. Biochip Array-Based Analysis of Plasma Cytokines in HIV Patients with Immunological and Virological Discordance. Scand. J. Immunol. 2007 ; 65 (6). 549-554 (Pubitemid 46808846)
44. Sertic J., Slavicek J., Bozina N., Malenica B., Kes P., Reiner Z. Cytokines and Growth Factors in Mostly Atherosclerotic Patients on Hemodialysis Determined by Biochip Array Technology. Clin. Chem. Lab. Med. 2007 ; 45 (10). 1347-1352 (Pubitemid 47557087)
45. Lawless M. W., White M., Mankan A. K., O'Dwyer M. J., Norris S. Elevated MCP-1 Serum Levels Are Associated with the H63D Mutation and Not the C282Y Mutation in Hereditary Hemochromatosis. Tissue Antigens. 2007 ; 70 (4). 294-300 (Pubitemid 47340724)
46. Kavsak P. A., Ko D. T., Newman A. M., Palomaki G. E., Lustig V., MacRae A. R., Jaffe A. S. Risk Stratification for Heart Failure and Death in an Acute Coronary Syndrome Population Using Inflammatory Cytokines and N-Terminal Pro-Brain Natriuretic Peptide. Clin. Chem. 2007 ; 53 (12). 2112-2118 (Pubitemid 350197294)
47. Badiou S., Cristol J. P., Jaussent I., Terrier N., Morena M., Maurice F., Leray-Moragues H., Rivory J. P., Chalabi L., Delcourt C. Fine-Tuning of the Prediction of Mortality in Hemodialysis Patients by Use of Cytokine Proteomic Determination. Clin. J. Am. Soc. Nephrol. 2008 ; 3 (2). 423-430
48. Roh M. I., Kim H. S., Song J. H., Lim J. B., Kwon O. W. Effect of Intravitreal Bevacizumab Injection on Aqueous Humor Cytokine Levels in Clinically Significant Macular Edema. Ophthalmology. 2009 ; 116 (1). 80-86
49. Samnegard A., Hulthe J., Silveira A., Ericsson C. G., Hamsten A., Eriksson P. Gender Specific Associations between Matrix Metalloproteinases and Inflammatory Markers in Post Myocardial Infarction Patients. Atherosclerosis. 2009 ; 202 (2). 550-556
50. Leng S. X., McElhaney J. E., Walston J. D., Xie D., Fedarko N. S., Kuchel G. A. ELISA and Multiplex Technologies for Cytokine Measurement in Inflammation and Aging Research. J. Gerontol. A Biol. Sci. Med. Sci. 2008 ; 63 (8). 879-884